journal article·2023-12-31Open access

Identification and verification of pivotal genes promoting the progression of atherosclerosis based on WGCNA

Jing Wen, Tong Ren, Jinzhen Zheng, Xing Jiang, Yingxia Li, Xilin Jiang, Xin Jin, Hongying Zhao, Jingwen Li

Abstract

As the main pathological basis for the development of cardiovascular and cerebrovascular diseases, atherosclerosis (AS) seriously affects human health. The key targets of biological information analysis of AS can help exploit therapeutic targets. The expression data of early and progressive atherosclerotic tissues were downloaded from the Gene Expression Omnibus (GEO) database. Based on GSE28829 and GSE120521, 74 key genes were obtained through differential expression analysis and weighted correlation network analysis (WGCNA) analysis, which were mainly enriched in the regulating of inflammatory response, chemokine signalling pathway, apoptosis, lipid and AS, Toll-like receptor signalling pathway and so on according to the results of the enrichment analysis. Cytoscape software was applied to screen four pivotal genes (TYROBP, ITGB2, ITGAM and TLR2) based on PPI. The results of the correlation analysis showed that the expression level of pivotal genes was positively related to macrophages M0, and was negatively related to T cells follicular helper. In addition, the expression of ITGB2 was positively related to Tregs. In this study, bioinformatics was applied to screen pivotal genes affecting the progress of AS, which were significantly related to immune-related biological functions and signal pathways of atherosclerotic tissues and the infiltration level of immune cells. Therefore, pivotal genes were expected to become therapeutic targets for AS.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Atherosclerosis and Cardiovascular Diseases · Ferroptosis and cancer prognosis · interferon and immune responses

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Xiamen Cardiovascular Hospital of Xiamen University, School of Medcine, Xiamen University, Xiamen, China

Department of Neurosurgery, Xiang’an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China

Department of Endocrinology, Xiang’an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China

Department of Pediatrics, Zhongshan Hospital of Xiamen University, Xiamen University, Xiamen, China

Funding

National Natural Science Foundation of China · Scientific Research Fund of Xiang’an Hospital of Xiamen University

References (29)

Show source-provided references
1. 10.1016/j.jacc.2021.05.01110.1016/j.jacc.2021.05.011 ↗
2. 10.1038/s41586-021-03392-810.1038/s41586-021-03392-8 ↗
3. 10.1161/CIRCRESAHA.111.26138810.1161/CIRCRESAHA.111.261388 ↗
4. Ye Z · Front Immunol · 2022 · 13 · 90592110.3389/fimmu.2022.905921 ↗
5. 10.3389/fcvm.2022.83364210.3389/fcvm.2022.833642 ↗
6. Yang Y · Front Pharmacol · 2022 · 13 · 86562410.3389/fphar.2022.865624 ↗
7. 10.1080/21691401.2021.187379810.1080/21691401.2021.1873798 ↗
8. Toubiana D · J Comput Biol · 2019 · 26 · 134910.1089/cmb.2019.0221 ↗
9. 10.1093/bib/bbaa22410.1093/bib/bbaa224 ↗
10. 10.3389/fimmu.2021.65834110.3389/fimmu.2021.658341 ↗
11. Huang Q · Front Cardiovasc Med · 2020 · 7 · 58057310.3389/fcvm.2020.580573 ↗
12. 10.1016/j.ygeno.2016.04.00710.1016/j.ygeno.2016.04.007 ↗
13. Kong P · Signal Transduct Target Ther · 2022 · 7 · 13110.1038/s41392-022-00955-7 ↗
14. Hu H · Front Cardiovasc Med · 2021 · 8 · 10963
15. 10.1161/CIRCULATIONAHA.114.01231610.1161/CIRCULATIONAHA.114.012316 ↗
16. Evans TD · Circ Res · 2016 · 119 · 125810.1161/CIRCRESAHA.116.310155 ↗
17. 10.1016/j.cmet.2008.09.00510.1016/j.cmet.2008.09.005 ↗
18. Schwarz A · J Biomed Sci · 2017 · 24 · 1210.1186/s12929-017-0320-5 ↗
19. 10.1016/j.lfs.2019.11714210.1016/j.lfs.2019.117142 ↗
20. 10.1161/CIRCULATIONAHA.109.85188110.1161/CIRCULATIONAHA.109.851881 ↗
21. Pan Y · Lipids Health Dis · 2020 · 19 · 5410.1186/s12944-020-01222-w ↗
22. 10.1016/j.atherosclerosis.2015.06.05810.1016/j.atherosclerosis.2015.06.058 ↗
23. 10.1016/j.cmet.2010.09.01010.1016/j.cmet.2010.09.010 ↗
24. Huang R · Adv Sci · 2021 · 8 · e200416210.1002/advs.202004162 ↗
25. Hedl M · Proc Natl Acad Sci U S A · 2007 · 104 · 1944010.1073/pnas.0706097104 ↗
26. 10.1080/21655979.2021.192756010.1080/21655979.2021.1927560 ↗
27. 10.1038/s41577-021-00584-110.1038/s41577-021-00584-1 ↗
28. Wang H · J Clin Invest · 2008 · 118 · 262910.1172/JCI34916 ↗
29. Zhou M · J Immunol · 2021 · 207 · 178510.4049/jimmunol.2100070 ↗